ProCE Banner Activity

Treatment-Free Remission for Patients With CML: Where Are We Now

Clinical Thought
How are you managing your patients with CML after achieving a complete molecular remission on first-line TKI therapy? In this commentary, Prof. Brümmendorf shares his thoughts on treatment-free remission in patients with CML.

Released: September 21, 2020

Expiration: September 20, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.